Literature DB >> 14553869

Antibiotic-coated hemodialysis catheters for the prevention of vascular catheter-related infections: a prospective, randomized study.

Ioannis Chatzinikolaou1, Kevin Finkel, Hend Hanna, Maha Boktour, John Foringer, Tam Ho, Issam Raad.   

Abstract

PURPOSE: To determine the efficacy of minocycline-rifampin-coated hemodialysis catheters in reducing catheter-related infections in patients requiring hemodialysis for acute renal failure.
METHODS: Between May 2000 and March 2002, 66 patients were randomly assigned to receive a minocycline-rifampin-impregnated central venous catheter and 64 were randomly assigned to receive an unimpregnated catheter. Patients were followed prospectively until the catheter was removed. Catheter-related infection was determined through quantitative catheter cultures, quantitative blood cultures, or both.
RESULTS: Both groups of patients were similar in age, sex, underlying disease, type of dialysis (continuous vs. intermittent), neutropenia during catheterization and its duration, catheter insertion difficulties, and administration of blood products or medication. The mean (+/- SD) catheter dwell time was the same in both groups (8 +/- 6 days, P = 0.7). There were seven catheter-related infections (11%), all associated with the use of unimpregnated catheters. Kaplan-Meier estimates for the risk of catheter-related infection showed that coated catheters were less likely to be associated with infection (P = 0.006).
CONCLUSION: The use of polyurethane hemodialysis catheters impregnated with minocycline and rifampin decreases the risk of catheter-related infection in patients with acute renal failure.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14553869     DOI: 10.1016/s0002-9343(03)00367-x

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  20 in total

Review 1.  Anti-infective-treated central venous catheters: a systematic review of randomized controlled trials.

Authors:  B S Niël-Weise; T Stijnen; P J van den Broek
Journal:  Intensive Care Med       Date:  2007-10-17       Impact factor: 17.440

2.  What's new: prevention of acute dialysis catheter-related infection.

Authors:  Antoine Schneider; Ian Baldwin; Bertrand Souweine
Journal:  Intensive Care Med       Date:  2017-05-18       Impact factor: 17.440

3.  Comparison of antimicrobial impregnation with tunneling of long-term central venous catheters: a randomized controlled trial.

Authors:  Rabih O Darouiche; David H Berger; Nancy Khardori; Claudia S Robertson; Matthew J Wall; Michael H Metzler; Seema Shah; Mohammad D Mansouri; Colleen Cerra-Stewart; James Versalovic; Michael J Reardon; Issam I Raad
Journal:  Ann Surg       Date:  2005-08       Impact factor: 12.969

Review 4.  Prevention of catheter-related bloodstream infection in patients on hemodialysis.

Authors:  Michiel G H Betjes
Journal:  Nat Rev Nephrol       Date:  2011-03-22       Impact factor: 28.314

Review 5.  Ethanol lock is effective on reducing the incidence of tunneled catheter-related bloodstream infections in hemodialysis patients: a systematic review and meta-analysis.

Authors:  Tingting Zhao; Hong Liu; Jibin Han
Journal:  Int Urol Nephrol       Date:  2018-04-17       Impact factor: 2.370

6.  Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm.

Authors:  Issam Raad; Hend Hanna; Ying Jiang; Tanya Dvorak; Ruth Reitzel; Gassan Chaiban; Robert Sherertz; Ray Hachem
Journal:  Antimicrob Agents Chemother       Date:  2007-03-12       Impact factor: 5.191

7.  Comparative in vitro efficacies and antimicrobial durabilities of novel antimicrobial central venous catheters.

Authors:  Hend Hanna; Paul Bahna; Ruth Reitzel; Tanya Dvorak; Gassan Chaiban; Ray Hachem; Issam Raad
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

Review 8.  A state of the art review on optimal practices to prevent, recognize, and manage complications associated with intravascular devices in the critically ill.

Authors:  Jean-François Timsit; Mark Rupp; Emilio Bouza; Vineet Chopra; Tarja Kärpänen; Kevin Laupland; Thiago Lisboa; Leonard Mermel; Olivier Mimoz; Jean-Jacques Parienti; Garyphalia Poulakou; Bertrand Souweine; Walter Zingg
Journal:  Intensive Care Med       Date:  2018-05-12       Impact factor: 17.440

9.  Assessment of the Potential for Inducing Resistance in Multidrug-Resistant Organisms from Exposure to Minocycline, Rifampin, and Chlorhexidine Used To Treat Intravascular Devices.

Authors:  Joel Rosenblatt; Nylev Vargas-Cruz; Ruth A Reitzel; Issam I Raad
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

10.  [Central venous catheters as access for acute and long-term dialysis].

Authors:  M Hollenbeck; A Niehuus; G Wozniak; S Hennigs
Journal:  Chirurg       Date:  2012-09       Impact factor: 0.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.